Jagsonpal Pharmaceuticals standalone net profit rises 33.13% in the March 2026 quarter

Sales rise 9.63% to Rs 64.20 crore

Net profit of Jagsonpal Pharmaceuticals rose 33.13% to Rs 8.76 crore in the quarter ended March 2026 as against Rs 6.58 crore during the previous quarter ended March 2025. Sales rose 9.63% to Rs 64.20 crore in the quarter ended March 2026 as against Rs 58.56 crore during the previous quarter ended March 2025.

For the full year,net profit declined 22.18% to Rs 43.08 crore in the year ended March 2026 as against Rs 55.36 crore during the previous year ended March 2025. Sales rose 6.89% to Rs 287.23 crore in the year ended March 2026 as against Rs 268.72 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	64.20	58.56	10	287.23	268.72	7
OPM %	17.37	14.89	-	20.22	19.00	-
PBDT	14.07	11.23	25	69.04	58.30	18
PBT	11.75	8.92	32	59.60	50.17	19
NP	8.76	6.58	33	43.08	55.36	-22

Powered by Capital Market - Live News